Clinical Trial

Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation

Name: Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation — clinical trial record (NCT07589075)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SGLT-2/PCOS

Completed Phase 4

View on ClinicalTrials.gov →

Summary

The aim of the study is to assess the efficacy of adjuvant therapy dapagliflozin, metformin as monotherapy and combination of both in comparison to control group in induction of ovulation with letrozole in women PCOS, focusing specifically on rates of ovulation and pregnancy.

Trial Details

NCT Number	NCT07589075
Lead Sponsor	Beni-Suef University
Conditions	Induction of Ovulation
Enrollment	500 participants
Start Date	2023-10-20
Primary Completion	2024-07-01 (estimated)
Study Completion	2025-10-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-15